This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Kelly Horne Donaldson: Innovator in Therapeutic Biaryl Derivatives
Introduction
Kelly Horne Donaldson is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on therapeutic biaryl derivatives. Her research and inventions have the potential to impact the treatment of various medical conditions.
Latest Patents
Kelly Horne Donaldson holds a patent for therapeutic biaryl derivatives, which are described in her invention as having the formula (I) and include pharmaceutically acceptable derivatives. This patent represents her commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Throughout her career, Kelly has been associated with Glaxo Wellcome Inc., a leading pharmaceutical company. Her work there has allowed her to focus on developing new therapeutic agents that can enhance patient care and treatment outcomes.
Collaborations
Kelly has collaborated with notable colleagues, including Barry George Shearer and David Edward Uehling. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Kelly Horne Donaldson is a dedicated inventor whose work in therapeutic biaryl derivatives exemplifies her commitment to advancing healthcare. Her contributions to the pharmaceutical industry continue to pave the way for new treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile